Stock comparison
Cintas
CTAS$69.19BIndustrials Market cap, Sector
Emerson Electric
EMR$76.41BIndustrials Market cap, Sector
Overall winner
Cintas
CTAS 70 EMR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CTAS7wins
0winsEMR
77B
C61
84B
B72
72B
D52
68C
D59
69C
D46
80B
C61
75B
C60
Side-by-side metrics
| Metric | CTAS | EMR |
|---|---|---|
| Market cap | $69.19B | $76.41B Winner |
| P/E (TTM) | 34.9x | 30.5x Winner |
| EV/EBIT | 29.7x | 24.4x Winner |
| ROIC (TTM) | Winner: 23.17% | 7.73% |
| Gross margin | 50.36% | 52.66% Winner |
| Net margin | Winner: 17.57% | 13.35% |
| Revenue CAGR 5y | Winner: 9.79% | 8.64% |
| EPS CAGR 5y | Winner: 14.24% | 1.4% |
| Debt / Equity | Winner: 0.6x | 0.7x |
| Dividend yield | 1.07% | 1.65% Winner |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CTAS leads on
- EPS CAGR 5y14.24%vs 1.4%+90%
- ROIC (TTM)23.17%vs 7.73%+67%
- Net margin17.57%vs 13.35%+24%
- Revenue CAGR 5y9.79%vs 8.64%+12%
EMR leads on
- Dividend yield1.65%vs 1.07%+35%
- EV/EBIT24.4xvs 29.7x+18%
- P/E (TTM)30.5xvs 34.9x+13%
- Market cap$76.41Bvs $69.19B+9%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.